🔗 Permalink

Inventor profile of:

Joseph SCHOEPFER

City:

Riehen

Country:

Switzerland

Published Applications:

Last publication date:

2024-10-31

Top Assignees for applications by Joseph SCHOEPFER

The entities that hold a legal rights for patent applications filed by inventor SCHOEPFER Joseph:

NOVARTIS AG 19 Basel, Switzerland
IRM LLC 2 Hamilton, Bermuda
Novatis AG 1 Basel, Switzerland

Recent patent applications by SCHOEPFER Joseph

Joseph SCHOEPFER from Riehen, CH has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-10-31

US20240360118A1

Chemistry; metallurgy

Bicyclic Compounds and their Uses

#2 | 2024-07-25

US20240245694A1

Human necessities

Tricyclic Compounds and their Uses

#3 | 2024-06-20

US20240197715A1

Human necessities

PHARMACEUTICAL COMBINATIONS AND USES THEREOF

#4 | 2023-02-16

US20230046859A1

Chemistry; metallurgy

Bicyclic compounds and their uses

#5 | 2018-05-17

US20180134695A1

Chemistry; metallurgy

COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF ABL1, ABL2 AND BCR-ABL1

#6 | 2016-08-04

US20160220576A1

Human necessities

ISOXAZOLE COMPOUND FOR THE TREATMENT OF CANCER

#7 | 2016-07-14

US20160200705A1

Chemistry; metallurgy

Benzamide derivatives for inhibiting the activity of ABL1, ABL2 and BCR-ABL1

#8 | 2016-06-30

US20160185733A1

Chemistry; metallurgy

Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1

#9 | 2016-02-18

US20160045513A1

Human necessities

ISOXAZOLE COMPOUND FOR THE TREATMENT OF CANCER

#10 | 2015-07-02

US20150183801A1

Chemistry; metallurgy

Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1

#11 | 2015-05-21

US20150141427A1

Chemistry; metallurgy

Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1

#12 | 2015-05-07

US20150126485A1

Chemistry; metallurgy

Benzamide derivatives for inhibiting the activity of ABL1, ABL2 and BCR-ABL1

#13 | 2014-11-20

US20140343086A1

Chemistry; metallurgy

COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF ABL1, ABL2 AND BCR-ABL1

#14 | 2014-09-25

US20140288075A1

Human necessities

Isoxazole compound for the treatment of cancer

#15 | 2013-11-21

US20130310395A1

Chemistry; metallurgy

Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1

#16 | 2013-01-10

US20130012704A1

Chemistry; metallurgy

COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS

#17 | 2013-01-10

US20130012476A1

Chemistry; metallurgy

COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS

#18 | 2012-08-23

US20120214813A1

Human necessities

ISOXAZOLE COMPOUND FOR THE TREATMENT OF CANCER

#19 | 2012-04-05

US20120083496A1

Human necessities

ISOXAZOLE COMPOUND FOR THE TREATMENT OF CANCER

#20 | 2011-02-17

US20110039831A1

Chemistry; metallurgy

3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives

#21 | 2010-08-19

US20100210650A1

Human necessities

ISOXAZOLE COMPOUND FOR THE TREATMENT OF CANCER

#22 | 2009-05-28

US20090137804A1

Chemistry; metallurgy

Compounds and compositions as protein kinase inhibitors

#23 | 2009-03-12

US20090069341A1

Human necessities

INHIBITORS OF HSP90

#24 | 2009-02-12

US20090039811A1

Human necessities

Inhibitors of HSP90

#25 | 2008-12-18

US20080311038A1

Chemistry; metallurgy

Radicicol Derivatives Useful for Position Emission Tomography

#26 | 2007-10-25

US20070249639A1

Chemistry; metallurgy

Use of 9H-Purine-2,6-Diamine Derivatives in the Treatment of Proliferative Diseases and Novel 9H-Purine-2,6-Diamine Derivatives

#27 | 2007-07-19

US20070167449A1

Chemistry; metallurgy

Thiazole and pyrazole derivatives as Flt-3 kinase inhibitors

#28 | 2006-09-21

US20060211747A1

Human necessities

Methods of screening for compounds which inhibit the activity of Cdc34 in a zinc-mediated manner and compounds obtained by this method

#29 | 2005-08-04

US20050171105A1

Chemistry; metallurgy

Methods and compositions as protein kinase inhibitors

InventorID:

29799 ⎘